PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

about

c-Met in chromophobe renal cell carcinoma.Development of diagnostic model of lung cancer based on multiple tumor markers and data mining.

P2860

Q39051379-197165FA-E745-4EAF-8E49-C325D54D5315 Q47129139-99559A2B-B3BE-4088-84C2-798FEF79FFB8

P2860

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

Item

http://www.wikidata.org/entity/Q41553643

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

@en

type

Item

label

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

@en

prefLabel

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

@en

P1476

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

@en

P2093

Gu Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Gong

http://www.w3.org/2001/XMLSchema#string

Lulu Miao

http://www.w3.org/2001/XMLSchema#string

Yanjun Xu

http://www.w3.org/2001/XMLSchema#string

Yun Fan

http://www.w3.org/2001/XMLSchema#string

Yunyun Lu

http://www.w3.org/2001/XMLSchema#string

Zhiyu Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Programmed death ligand-1 expression in non-small cell lung cancer.

P304

53978-53988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9765

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28903317

http://www.w3.org/2001/XMLSchema#string

P932

5589556

http://www.w3.org/2001/XMLSchema#string

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

about

P2860

P2860

PD-L1 and c-MET expression and survival in patients with small cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932